STOCK TITAN

Acadia Healthcare (ACHC) Stock News, Mar-Sep 2025

ACHC Nasdaq

Acadia Healthcare Company, Inc. reports developments tied to its national behavioral healthcare services business. The company owns and operates acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers and outpatient behavioral health clinics serving communities in the United States and Puerto Rico.

Recurring news for ACHC includes quarterly operating results, same-facility revenue, patient days, admissions, revenue per patient day, adjusted EBITDA guidance and performance across its facility categories. Company updates also cover facility network changes, investor conference participation, board composition, executive leadership transitions and operational initiatives in behavioral healthcare and recovery services.

Rhea-AI Summary

Acadia Healthcare (NASDAQ: ACHC) has issued a statement reaffirming its commitment to enhancing long-term shareholder value. The company outlined its strategic focus on disciplined growth in behavioral health and substance use disorder treatment services.

The company's strategy includes expanding access to behavioral healthcare, improving clinical outcomes, and driving operational efficiency across its network. Acadia is also working to optimize its portfolio to enhance cash flow and strengthen its financial position. The company has retained Goldman Sachs and J.P. Morgan as financial advisors and Kirkland & Ellis LLP as legal advisor.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.67%
Tags
none
-
Rhea-AI Summary

Engine Capital LP, owning approximately 3% of Acadia Healthcare (NASDAQ: ACHC), has sent a critical letter to the company's Board of Directors highlighting significant concerns about the company's performance and management. The activist investor points to negative returns and underperformance compared to other healthcare facility operators.

Engine Capital criticizes several aspects of Acadia's operations, including poor execution, flawed reorganization under CEO Christopher Hunter, increasing costs, inadequate capital allocation, and insufficient board oversight. The investor demands immediate actions, including halting growth capital projects, improving operations and cost structure, considering asset sales, and implementing share repurchases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.67%
Tags
management
-
Rhea-AI Summary

Acadia Healthcare (NASDAQ: ACHC) announced its participation in the upcoming Jefferies 2025 Healthcare Services Conference, scheduled for September 29-30, 2025, in Nashville, Tennessee. The company will participate in a fireside chat, which will be available via webcast starting at 9:35 AM ET on September 29, 2025.

Investors can access the live presentation through the "Investors" section of Acadia's website. A replay will remain available for 30 days following the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.97%
Tags
conferences
Rhea-AI Summary

ECU Health and Acadia Healthcare (NASDAQ:ACHC) celebrated the ribbon-cutting of their new 144-bed behavioral health hospital in Greenville, North Carolina. The state-of-the-art facility, opening in September 2025, is a joint venture between the two organizations aimed at expanding mental health services in eastern North Carolina.

The hospital will provide inpatient and intensive outpatient programs for adults, seniors, children, and adolescents dealing with mental health conditions. Located near ECU Health Medical Center, it will also serve as a training site for students and residents through partnerships with ECU's Brody School of Medicine, addressing the region's shortage of behavioral health professionals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.2%
Tags
none
-
Rhea-AI Summary

Acadia Healthcare (NASDAQ: ACHC) reported strong Q2 2025 financial results with revenue of $869.2 million, up 9.2% year-over-year. The company achieved same facility revenue growth of 9.5%, driven by a 7.5% increase in revenue per patient day and 1.8% growth in patient days.

Key highlights include net income of $30.1 million ($0.33 per diluted share), adjusted EBITDA of $201.8 million (up 7.6%), and the addition of 101 new licensed beds. The company recognized a $51.8 million pre-tax benefit from Tennessee's supplemental program and updated its 2025 guidance with revenue projected at $3.3-3.35 billion.

Additionally, Acadia announced CFO Heather Dixon will step down effective August 15, 2025, with Tim Sides serving as interim CFO.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.28%
Tags
-
Rhea-AI Summary

Acadia Healthcare (NASDAQ: ACHC) has scheduled its second quarter 2025 earnings release for Tuesday, August 5, 2025, after market close. The company will host a conference call with institutional investors and analysts on Wednesday, August 6, 2025, at 9:00 a.m. ET.

The conference call will be accessible via live webcast on the company's website at www.acadiahealthcare.com in the "Investors" section, with the recording remaining available for 30 days following the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.73%
Tags
Rhea-AI Summary
Acadia Healthcare (NASDAQ: ACHC) reported its Q1 2025 financial results with revenue of $770.5 million, a slight increase from $768.1 million in Q1 2024. The company's same-facility revenue grew 2.1%, with patient days up 2.2%. Net income was $8.4 million ($0.09 per diluted share), while adjusted income reached $36.9 million ($0.40 per diluted share). Adjusted EBITDA totaled $134.2 million. Key operational highlights include the addition of 378 newly licensed beds and seven new comprehensive treatment centers (CTCs), expanding to 170 CTCs across 33 states. The company launched two new facilities in Florida and Michigan. Acadia initiated a $300 million share repurchase program, buying back 1.6 million shares for $47.3 million in Q1. The company affirmed its 2025 guidance, projecting revenue of $3.3-3.4 billion, Adjusted EBITDA of $675-725 million, and plans to add 800-1,000 beds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.26%
Tags
-
Rhea-AI Summary

Acadia Healthcare (NASDAQ: ACHC) has announced its participation in the BofA Securities 2025 Health Care Conference, scheduled for May 13-15, 2025, in Las Vegas, Nevada. The company will deliver a presentation on Wednesday, May 14th, 2025, at 1:20 p.m. Central Time (11:20 a.m. Pacific Time). Investors can access the live webcast of the presentation through the "Investors" section of Acadia's website at www.acadiahealthcare.com. A replay of the presentation will remain available on the company's website for 30 days following the event.

[ { "q": "When is Acadia Healthcare (ACHC) presenting at the BofA Securities Health Care Conference 2025?", "a": "Acadia Healthcare will present on Wednesday, May 14th, 2025, at 1:20 p.m. Central Time (11:20 a.m. Pacific Time)." }, { "q": "How can I watch Acadia Healthcare's presentation at the BofA Securities conference?", "a": "The presentation can be accessed via live webcast through the 'Investors' section of Acadia's website (www.acadiahealthcare.com)." }, { "q": "How long will Acadia Healthcare's BofA Securities conference presentation replay be available?", "a": "The presentation replay will be available on Acadia Healthcare's website for 30 days after the event." }, { "q": "Where is the BofA Securities 2025 Health Care Conference being held?", "a": "The conference is being held in Las Vegas, Nevada." } ]
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.25%
Tags
conferences
-
Rhea-AI Summary

Acadia Healthcare (NASDAQ: ACHC) has scheduled its first quarter 2025 earnings release for Monday, May 12, 2025, after market close. The company will host a conference call with institutional investors and analysts on Tuesday, May 13, 2025, at 8:30 a.m. ET.

Additionally, the company announced that CFO Heather Dixon will take a brief medical leave starting April 18, 2025, for a planned medical procedure. During her absence, Acadia's senior finance leadership team and executive management will manage her responsibilities. Dixon is expected to participate in the May 13 earnings call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
Rhea-AI Summary

Acadia Healthcare (NASDAQ: ACHC) has announced the pricing of its private offering of $550 million in senior notes due 2033, representing a $50 million increase from its previous announcement. The notes will bear interest at 7.375% per year, payable semi-annually on March 15 and September 15, starting September 15, 2025.

The offering is expected to close on March 10, 2025, subject to customary conditions. The notes were offered at 100.000% of the principal amount and will mature on March 15, 2033. Acadia plans to use the proceeds to prepay outstanding borrowings under its existing senior secured revolving line of credit.

The notes are being offered exclusively to qualified institutional buyers under Rule 144A and non-U.S. persons under Regulation S of the Securities Act.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.21%
Tags
none

FAQ

What is the current stock price of Acadia Healthcare (ACHC)?

The current stock price of Acadia Healthcare (ACHC) is $27.5 as of September 30, 2026.

What is the market cap of Acadia Healthcare (ACHC)?

The market cap of Acadia Healthcare (ACHC) is approximately 2.6B.